My interview with Pepper Bio CEO Jon Hu begins with one of the most frequently repeated phrases I hear when speaking with drug developers: “We are a drug developer trying to tackle untreatable ...
NFX’s Fund III, its largest fund to date, and one of the largest pre-seed and seed-focused funds ever, doubles down on early seed stage startups focusing on a broad range of sectors including fintech, ...
BERKELEY, Calif.--(BUSINESS WIRE)--Radar Therapeutics, a biotech company developing smart programmable medicines, today announced the completion of an oversubscribed $13.4 million in seed financing ...
NFX’s Fund III, its largest fund to date, and one of the largest pre-seed and seed-focused funds ever, doubles down on early seed stage startups focusing on a broad range of sectors including fintech, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results